Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
Commentary|Slideshows|August 17, 2023
CDC 2023 Immunization Updates for 5 Vaccine-Preventable Illnesses
Author(s)Kenneth Bender, PharmD, MA
Advertisement
The US Centers for Disease Control and Prevention (CDC) issued updated immunization schedules in February 2023 for both adults and children.
The following Guideline Topline highlights updates in the immunization schedule for: pneumococcal disease; measles, mumps, and rubella; hepatitis B; polio; and monkeypox.
In an
Where relevant, we note recommendations from recent meetings of the CDC's Advisory Committee on Immunization Practices (
Advertisement
Related to this article
Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank study of dietary patterns.
Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
October FDA news included updates on long-acting olanzapine, multi-cancer blood testing, stroke rehabilitation, and heart failure monitoring.
Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.
TMS 2026: Menopause was coded in just 7.8% of midlife outpatient visits. Arina Chesnokova, MD, MPH, discusses diagnosis gaps, prescribing risks, and solutions for primary care.
Investigational CagriSema produced 23.1% to 26.7% weight loss across menopause stages at 68 weeks, with improvements in cardiometabolic risk factors.
Advertisement
Advertisement
Trending on Patient Care Online
1
4 FDA Decisions for Primary Care to Know from October 2026
2
Abbott's Amulet 360 Linked to Low Stroke Risk at 1 Year in Late-Breaking Research
3
When Night Sweats Signal Something Other Than Menopause
4
New Schizophrenia Treatment Addresses Long-Standing LAI Barriers
5